| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680452 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2018 | 8 Pages |
Abstract
In clinical trials of Alzheimer's disease, mixed-model repeated measure analysis with relaxed assumptions on disease progression seems to be preferred. The slope model might be more powerful if the trajectory has little departure from linearity.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Yun-Fei Chen, Xiao Ni, Adam S. Fleisher, Wei Zhou, Paul Aisen, Richard Mohs,